2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O10] Oral Session 10　Cross-sectional Program
【E】

Fri. Feb 18, 2022 10:00 AM - 11:30 AM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Maki Tanioka（Clinical AI, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Oakayama University），Yoichi Naito（Department of General Internal Medicine/Experimental Therapeutics/Medical Oncology, National Cancer Center Hospital East）
Discussant：Yasutoshi Kuboki（Department of Experimental Therapeutics, National Cancer Center Hospital East）

[O10-2] First-in-Human DuoBody® -CD40x4-1BB (GEN1042) Trial: Safety and Initial Clinical Activity in Advanced Solid Tumors

○Melissa Johnson1, Juanita Lopez2, Patricia Lorusso3, Jessica Bauman4, Daniel Haggstrom5, Eleni Lagkadinou6, Gaurav Bajaj7, Ozlem Tureci6, Homer C. Adams Iii7, Ugur Sahin6, Yali Fu7, Tahamtan Ahmadi7, Kristoffer S. Rohrberg8 (1.Sarah Cannon Research Institute, Nashville, TN, USA, 2.Royal Marsden NHS Foundation Trust, Sutton, UK, 3.Yale Cancer Center, New Haven, CT, USA, 4.Fox Chase Cancer Center, Philadelphia, PA, USA, 5.Levine Cancer Institute, Charlotte, NC, USA, 6.BioNTech SE, Mainz, Germany, 7.Genmab, Princeton, NJ, USA, 8.Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password